Kymera Therapeutics’ $316.2 Million Common Stock Offering

Leila Ahmed
Tagged:

Goodwin Procter advised Kymera Therapeutics, Inc. on the offering, and Wilmer Cutler Pickering Hale and Dorr advised the underwriters.Kymera Therapeutics, Inc. (Nasdaq: KYMR) (“Kymera”) announced its public…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

…

This content is for Standard 1 Year members only.
Login Join Now